New FDC - BE reference products [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2015-11-09 09:48 (3381 d 11:25 ago) – Posting: # 15627
Views: 3,149

Dear nobody
As I explained, it is a new fixed dose combination with known APIs, there is no reference product in the strict sense, only mono product references but if you do not aim for substitution indication (according to §10(b)) but go for a mixed application according to §8.3 do you need to demonstrate BE against the European mono products?
Looking forward to your reply.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,379 posts in 4,913 threads, 1,661 registered users;
245 visitors (0 registered, 245 guests [including 23 identified bots]).
Forum time: 21:13 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5